Corporate engagement steps back in 2025, consumers feel the holidays are less affordable, OpenAI generates Disney magic.
Introduction Cognitive impairment is a common consequence after stroke. Intermittent theta burst stimulation (iTBS) has emerged as a promising cognitive therapy. However, traditional iTBS typically ...
Get insights on Biogen’s Leqembi sales outlook, clinical value, risks, and what new drug approvals may mean for investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback